Sijmen de Vries
Vermögen: - $ am 30.09.2026
Vermögen: - $ am 30.09.2026
Dr. Sijmen de Vries is an Independent Non-Executive Director at Biodexa Pharmaceuticals Plc, a Chief Executive Officer at Pharming Intellectual Property BV and a Finish Partner at BioConnection BV.
He is on the Board of Directors at Mendus AB, Biodexa Pharmaceuticals Plc and Sylus Pharmaceuticals Ltd. Dr. de Vries was previously employed as an Executive Director by Pharming Group NV, a Non-Executive Director by Midatech Ltd., a Chief Executive Officer by 4-Antibody AG, and a Chief Executive Officer by Morphochem AG.
He received his MBA from Ashridge Business School and a doctorate degree from the University of Amsterdam.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.03.2026 | 0 ( -.--% ) | - $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BIODEXA PHARMACEUTICALS PLC | Direktor/Vorstandsmitglied | 13.11.2014 |
| MENDUS AB | Direktor/Vorstandsmitglied | 01.01.2026 |
Sylus Pharmaceuticals Ltd. | Direktor/Vorstandsmitglied | 21.06.2010 |
Pharming Intellectual Property BV
Pharming Intellectual Property BV Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures milking equipment | Vorstandsvorsitzender | - |
BioConnection BV
BioConnection BV BiotechnologyHealth Technology Provides biopharmaceutical services | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
| PHARMING GROUP N.V. | Vorstandsvorsitzender | 04.03.2025 |
Midatech Ltd.
Midatech Ltd. BiotechnologyHealth Technology Engages in discovery and the development of nanomedicine pharmaceutical products | Direktor/Vorstandsmitglied | 13.03.2015 |
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Vorstandsvorsitzender | - |
Morphochem AG
Morphochem AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops drugs | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
Pharming Group NV
Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
Morphochem AG
Morphochem AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops drugs | Commercial Services |
University of Amsterdam
University of Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Ashridge Business School
Ashridge Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioConnection BV
BioConnection BV BiotechnologyHealth Technology Provides biopharmaceutical services | Health Technology |
Midatech Ltd.
Midatech Ltd. BiotechnologyHealth Technology Engages in discovery and the development of nanomedicine pharmaceutical products | Health Technology |
Sylus Pharmaceuticals Ltd. | |
Mendus AB
Mendus AB BiotechnologyHealth Technology Develops immunotherapies for therapeutic treatment of cancer | Health Technology |
Biodexa Pharmaceuticals Plc
Biodexa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Designs and manufactures nanomedicines | Health Technology |
Pharming Intellectual Property BV
Pharming Intellectual Property BV Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures milking equipment | Producer Manufacturing |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen